These new data will be considered as the CDC develops its next revision of the U.S. STD treatment guidelines, due out next year, Dr. Kirkcaldy said.
The study was sponsored by the National Institute of Allergy and Infectious Diseases. Dr. Kirkcaldy said he had no relevant financial disclosures.
On Twitter @mitchelzoler